Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do SciELO, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release

Texto completo
Autor(es):
Andressa Maria Pironi [1] ; Josimar de Oliveira Eloy [2] ; Camila Fernanda Rodero [3] ; Selma Gutierrez Antonio [4] ; Jovan Duran Alonso [5] ; Marlus Chorilli [6]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] São Paulo State University. Department of Drugs and Medicines. School of Pharmaceutical Sciences - Brasil
[2] Federal University of Ceara. Department of Pharmacy - Brasil
[3] São Paulo State University. Department of Drugs and Medicines. School of Pharmaceutical Sciences - Brasil
[4] São Paulo State University. Chemistry Institute. Department of Chemistry - Brasil
[5] São Paulo State University. Chemistry Institute. Department of Chemistry - Brasil
[6] São Paulo State University. Department of Drugs and Medicines. School of Pharmaceutical Sciences - Brasil
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: Brazilian Journal of Pharmaceutical Sciences; v. 59, 2023-04-14.
Resumo

Abstract Solid dispersions (SDs) of ursolic acid (UA) were developed using polyvinylpyrrolidone K30 (PVP K30) in combination with non-ionic surfactants, such as D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) or poloxamer 407 (P407) with the aim of enhancing solubility and in vitro release of the UA. SDs were investigated using a 24 full factorial design, subsequently the selected formulations were characterized for water solubility, X-ray diffractometry (XRD), differential scanning calorimetry (DSC), particle diameter, scanning electron microscopy, drug content, physical-chemical stability and in vitro release profile. SDs showed higher UA water-solubility than physical mixtures (PMs), which was attributed by transition of the drug from crystalline to amorphous or molecular state in the SDs, as indicated by XRD and DSC analyses. SD1 (with P407) and SD2 (with TPGS) were chosen for further investigation because they had higher drug load. SD1 proved to be more stable than SD2, revealing that P407 contributed to ensure the stability of the UA. Furthermore, SD1 and SD2 increased UA release by diffusion and swelling-controlled transport, following the Weibull model. Thus, solid dispersions obtained with PVP k-30 and P407 proved to be advantageous to enhance aqueous solubility and stability of UA. (AU)

Processo FAPESP: 16/22544-0 - Dispersões sólidas de ácido ursólico veiculadas em hidrogéis para administração cutânea: desenvolvimento, caracterização e avaliação biológica in vitro e in vivo
Beneficiário:Andressa Maria Pironi
Modalidade de apoio: Bolsas no Brasil - Mestrado